These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2392 related articles for article (PubMed ID: 24877633)

  • 1. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
    Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
    Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive and metabolic phenotype of a mouse model of PCOS.
    van Houten EL; Kramer P; McLuskey A; Karels B; Themmen AP; Visser JA
    Endocrinology; 2012 Jun; 153(6):2861-9. PubMed ID: 22334715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
    Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
    Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.
    Lai H; Jia X; Yu Q; Zhang C; Qiao J; Guan Y; Kang J
    Biol Reprod; 2014 Nov; 91(5):127. PubMed ID: 25100714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
    Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
    Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
    Ji SY; Liu XM; Li BT; Zhang YL; Liu HB; Zhang YC; Chen ZJ; Liu J; Fan HY
    Mol Hum Reprod; 2017 Oct; 23(10):698-707. PubMed ID: 28961951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
    Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
    Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
    [No Abstract]   [Full Text] [Related]  

  • 10. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
    Xiong T; Rodriguez Paris V; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA
    Am J Physiol Endocrinol Metab; 2022 Aug; 323(2):E145-E158. PubMed ID: 35658542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.
    Paixão L; Ramos RB; Lavarda A; Morsh DM; Spritzer PM
    Reprod Biol Endocrinol; 2017 Feb; 15(1):12. PubMed ID: 28183310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
    Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
    Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model.
    Cox MJ; Edwards MC; Rodriguez Paris V; Aflatounian A; Ledger WL; Gilchrist RB; Padmanabhan V; Handelsman DJ; Walters KA
    Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32301482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
    Ryan GE; Malik S; Mellon PL
    Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brown adipose tissue activation by rutin ameliorates polycystic ovary syndrome in rat.
    Hu T; Yuan X; Ye R; Zhou H; Lin J; Zhang C; Zhang H; Wei G; Dong M; Huang Y; Lim W; Liu Q; Lee HJ; Jin W
    J Nutr Biochem; 2017 Sep; 47():21-28. PubMed ID: 28501702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA; Shin SY; Yoon BK; Choi D
    Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rodent models for human polycystic ovary syndrome.
    Walters KA; Allan CM; Handelsman DJ
    Biol Reprod; 2012 May; 86(5):149, 1-12. PubMed ID: 22337333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
    Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
    PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.
    Caldwell ASL; Edwards MC; Desai R; Jimenez M; Gilchrist RB; Handelsman DJ; Walters KA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3334-E3343. PubMed ID: 28320971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 120.